Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Elixir Department: SOP for Cleaning Between Product Changeover – V 2.0

Posted on By

Elixir Department: SOP for Cleaning Between Product Changeover – V 2.0

Standard Operating Procedure for Cleaning Between Product Changeover in Elixir Manufacturing

Department Elixir Department
SOP No. SOP/ELX/169/2025
Supersedes SOP/ELX/169/2022
Page No. Page 1 of 11
Issue Date 11/04/2025
Effective Date 15/04/2025
Review Date 11/04/2026

1. Purpose

To establish a validated and standardized cleaning procedure to be followed between manufacturing of two different products in the Elixir Department, in order to prevent cross-contamination and ensure regulatory compliance.

2. Scope

This SOP applies to all equipment, utensils, contact surfaces, and processing areas used for elixir manufacturing that are shared across multiple products and require cleaning during product changeover.

3. Responsibilities

  • Production Operator:
    • Carry out cleaning activities as per this SOP and document the same.
  • QA Officer:
    • Verify cleaning and perform swab/rinse sampling as applicable.
    • Approve equipment for next product use.
  • Engineering Department:
    • Provide maintenance support and ensure cleaning tools and utilities are functional.
See also  Elixir Department: SOP for Endotoxin Testing - V 2.0

4. Accountability

The Production Head is accountable for cleaning execution and compliance. The QA Head is responsible for final verification and release of equipment post-cleaning. The Engineering Head ensures readiness of cleaning utilities and tools.

5. Procedure

5.1 Evaluation Before Cleaning

  1. Refer to the product changeover matrix or cleaning classification chart to determine the type of cleaning required (Type A – Similar product, Type B – Different product, Type C – Potent/Allergenic product).
  2. Identify all equipment and accessories used in the previous product.
  3. Ensure batch records and product status labels are updated before initiating cleaning.

5.2 Cleaning Process

  1. Perform dry cleaning to remove gross residues (scraping, brushing).
  2. Follow with wet cleaning using approved detergent solution (1% neutral or validated cleaning agent).
  3. For CIP systems:
    • Run standard cycle with pre-rinse, detergent wash, intermediate rinse, and final rinse.
  4. For manual cleaning:
    • Scrub interior and exterior surfaces with lint-free cloths or soft brushes.
    • Pay attention to blind spots, gaskets, and joints.
  5. Rinse thoroughly with purified water until pH of rinse water matches PW and no foam is observed.
  6. Use hot purified water if applicable for enhanced cleaning efficiency.
See also  Elixir Department: SOP for Intermediate Holding Studies - V 2.0

5.3 Inspection and Verification

  1. Perform visual inspection under adequate lighting to ensure “visibly clean” status.
  2. Collect swab/rinse samples from defined locations (minimum 3 per equipment).
  3. Submit samples to QC for:
    • Residue check (UV/vis, HPLC, or TOC)
    • Microbial analysis (TVC and pathogens)
  4. Equipment shall be labeled as “CLEANED – PENDING APPROVAL” until QA review is completed.

5.4 Approval and Release

  1. QA shall review swab/rinse test results against predefined limits.
  2. Upon satisfactory results, QA shall approve equipment for the next batch and sign off in the logbook.
  3. Update the cleaning status label to “CLEANED – READY FOR USE.”

6. Abbreviations

  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • CIP: Clean-In-Place
  • TOC: Total Organic Carbon
  • TVC: Total Viable Count
See also  Elixir Department: SOP for Heavy Metal Testing - V 2.0

7. Documents

  1. Product Changeover Cleaning Logbook (Annexure-1)
  2. Swab/Rinse Sample Report
  3. Cleaning Verification Checklist

8. References

  • 21 CFR Part 211.67 – Equipment Cleaning and Maintenance
  • ICH Q7 – GMP for APIs
  • WHO TRS 986 Annex 4 – Cleaning Validation

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Product Changeover Cleaning Logbook

Date Previous Product Next Product Equipment ID Cleaning Type Performed By QA Verified Remarks
11/04/2025 Elixir-A Elixir-B MXR-ELX-08 Type B Rajesh Kumar Sunita Reddy Approved

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
01/01/2024 1.0 Initial SOP Release New SOP QA Head
11/04/2025 2.0 Added cleaning classification and sampling strategy GMP Enhancement QA Head
Elixers V 2.0 Tags:Elixir colorants, Elixir dosage form, Elixir filtration techniques, Elixir flavoring agents, Elixir formulation, Elixir GMP compliance, Elixir manufacturing process, Elixir manufacturing SOPs, Elixir packaging requirements, Elixir pharmacopoeial standards, Elixir preparation methods, Elixir preservatives, Elixir production equipment, Elixir quality control, Elixir regulatory guidelines, Elixir shelf life, Elixir stability testing, Elixir sterilization methods, Elixir storage conditions, Elixir sweetening agents, Elixir viscosity modifiers, Hydroalcoholic solutions, Medicated elixirs, Non-medicated elixirs, Pharmaceutical elixirs

Post navigation

Previous Post: Biosimilars: SOP for In-Process Sample Collection During Purification – V 2.0
Next Post: Analytical Method Development: SOP for MACO Calculation for Cleaning Method – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2026 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version